A twin enrichment method based on dual-template molecularly imprinted polymer and dispersive liquid-liquid microextraction for simultaneous determination of two COVID-19 medicines in biological fluids.

A twin enrichment method based on dual-template molecularly imprinted polymer and dispersive liquid-liquid microextraction for simultaneous determination of two COVID-19 medicines in biological fluids.

Publication date: Sep 01, 2026

This study introduces a twin enrichment strategy based on dual-template molecularly imprinted polymer-assisted solid-phase microextraction coupled with dispersive liquid-liquid microextraction (MISPE-DLLME) for the simultaneous extraction and determination of favipiravir and remdesivir in biological matrices (blood and urine), followed by high-performance liquid chromatography with ultraviolet detection (HPLC-UV) analysis. The dual-template molecularly imprinted polymer (DT-MIP) was synthesized via precipitation polymerization and comprehensively characterized using Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), field-emission scanning electron microscopy (FESEM), Brunauer-Emmett-Teller (BET) surface area analysis, simultaneous thermal analysis (STA), and X-ray diffraction (XRD). Under optimized conditions, including pH 2. 00 +/- 0. 1, 10. 0 mg of MIP, 200 +/- 5 μL of 1-dodecanol, 500 +/- 10 μL of methanol, and an extraction time of 10. 0 +/- 0. 5 min, the method afforded high recoveries of 103-110% with relative standard deviations (RSDs) below 5% (n = 3). The method showed excellent sensitivity, with limits of detection of 1. 0 ng/mL for favipiravir and 0. 40 ng/mL for remdesivir and limits of quantification of 3. 3 ng/mL and 1. 3 ng/mL, respectively. Selectivity was evaluated against ten structurally related drugs (ibuprofen, gemfibrozil, paracetamol, diazepam, clobazam, methocarbamol, theophylline, naproxen, dimenhydrinate, and cinnarizine) at various concentration ratios, and the DT-MIP displayed superior recognition performance compared with the corresponding non-imprinted polymer (NIP). Analysis of clinical samples yielded acceptable recoveries and precision, confirming the reliability of the proposed method and its potential applicability in therapeutic drug monitoring of COVID-19 antivirals.

Concepts Keywords
40ng Adenosine Monophosphate
Biomed Adenosine Monophosphate
Chromatography Alanine
Drugs Alanine
Ph2 Amides
Amides
Antiviral Agents
Antiviral Agents
COVID-19
COVID-19 Drug Treatment
favipiravir
Favipiravir
HPLC-UV
Humans
Limit of Detection
Linear Models
Liquid Phase Microextraction
Molecular Imprinting
Molecularly Imprinted Polymers
Molecularly Imprinted Polymers
Pyrazines
Pyrazines
remdesivir
Remdesivir
Reproducibility of Results
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19
drug DRUGBANK Favipiravir
disease MESH MIP
drug DRUGBANK 1-DODECANOL
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Ibuprofen
drug DRUGBANK Gemfibrozil
drug DRUGBANK Acetaminophen
drug DRUGBANK Diazepam
drug DRUGBANK Clobazam
drug DRUGBANK Methocarbamol
drug DRUGBANK Theophylline
drug DRUGBANK Naproxen
drug DRUGBANK Dimenhydrinate
drug DRUGBANK Cinnarizine
drug DRUGBANK Adenosine phosphate
drug DRUGBANK L-Alanine

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *